Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARCA Biopharma Inc (NASDAQ:ABIO)

3.35
Delayed Data
As of May 27
 +0.01 / +0.30%
Today’s Change
3.05
Today|||52-Week Range
10.85
-27.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$30.4M

Company Description

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.

Contact Information

ARCA biopharma, Inc.
11080 CirclePoint Road
Westminster Colorado 80020
P:(720) 940-2100
Investor Relations:
(720) 940-2163

Employees

Shareholders

Other institutional28.07%
Mutual fund holders24.70%
Individual stakeholders1.42%

Top Executives

Michael R. BristowPresident, Chief Executive Officer & Director
Thomas A. KeuerChief Operating Officer
Brian L. SelbyChief Financial & Accounting Officer
Christopher David OzeroffSecretary, Senior Vice President & General Counsel
Derek K. ColeVice President-Investor Relations & Communications